RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      사람 탯줄혈액으로부터 다분화능 중간엽 줄기세포의 분리 및 분화 = Isolation and Differentiation of Multi-Potent Mesenchymal Stem Cells from Human Umbilical Cord Blood

      한글로보기

      https://www.riss.kr/link?id=A104466765

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Human umbilical cord blood (UCB) has been regarded as an alternative source for cell transplantation and cell therapy due to its hematopoietic potential of generating all blood cells, and mesenchymal potential of differentiating into various cells of a mesodermal origin. In this study, we pursued to isolate mesenchymal stem cells (MSCs) from UCB and to induce them to differentiate into possibly many tissue-specific cell types. During the cell culture expansion, UCB-derived mononuclear cells gave rise to adherent layers of fibroblast-like cells expressing MSCs-related antigens such as SH2, SH3, ASMA, CD13, CD29, and CD49e. Moreover, the study showed that these cells, in appropriate differentiation conditions, could differentiate, at least, into skeletal myoblasts, osteoblasts, and neuronal cells, as judged by RT-PCR, immunocytochemistry, and immunofluorescent staining against several tissue-specific markers. Our results indicate that UCB may be an alternative source of MSCs to bone marrow as UCB-derived MSCs possess a multipotency of skeletal myogenic, osteogenic, and neurogenic differentiation. And it also implies that these cells may become a suitable source for cell-based therapy as well as a useful tool of tissue engineering.
      번역하기

      Human umbilical cord blood (UCB) has been regarded as an alternative source for cell transplantation and cell therapy due to its hematopoietic potential of generating all blood cells, and mesenchymal potential of differentiating into various cells of ...

      Human umbilical cord blood (UCB) has been regarded as an alternative source for cell transplantation and cell therapy due to its hematopoietic potential of generating all blood cells, and mesenchymal potential of differentiating into various cells of a mesodermal origin. In this study, we pursued to isolate mesenchymal stem cells (MSCs) from UCB and to induce them to differentiate into possibly many tissue-specific cell types. During the cell culture expansion, UCB-derived mononuclear cells gave rise to adherent layers of fibroblast-like cells expressing MSCs-related antigens such as SH2, SH3, ASMA, CD13, CD29, and CD49e. Moreover, the study showed that these cells, in appropriate differentiation conditions, could differentiate, at least, into skeletal myoblasts, osteoblasts, and neuronal cells, as judged by RT-PCR, immunocytochemistry, and immunofluorescent staining against several tissue-specific markers. Our results indicate that UCB may be an alternative source of MSCs to bone marrow as UCB-derived MSCs possess a multipotency of skeletal myogenic, osteogenic, and neurogenic differentiation. And it also implies that these cells may become a suitable source for cell-based therapy as well as a useful tool of tissue engineering.

      더보기

      참고문헌 (Reference)

      1 "?Unrelated umbilical cord blood transplantation in adult patients" 772-780, 2003

      2 "?Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia" 489-191, 2004

      3 "?Searching for alternative sources of postnatal human mesenchymal stem cells candidate MSC-like cells from umbilical cord" 105-110, 2003

      4 "?Multilineage differentiation activity by cells isolated from umbilical cord blood expression of bone" 581-588, 2001

      5 "?Multilineage cells from human adipose tissue implications for cell-based therapies" 211-228, 2001

      6 "?Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 cells in NOD/SCID mice.?Exp. Hematol." 870-878, 2002

      7 "?Isolation of human mesenchymal stem cells" bone marrow versus umbilical cord blood 1099-1100, 2001

      8 "?Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors" 1815-18222001

      9 "?Biology of Hematopoietic Stem Cells Implications for Clinical Application" 759-806, 2003

      10 "P. S. in 't Anker ?Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34 cells in NOD/SCID mice" 881-889, 2003

      1 "?Unrelated umbilical cord blood transplantation in adult patients" 772-780, 2003

      2 "?Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia" 489-191, 2004

      3 "?Searching for alternative sources of postnatal human mesenchymal stem cells candidate MSC-like cells from umbilical cord" 105-110, 2003

      4 "?Multilineage differentiation activity by cells isolated from umbilical cord blood expression of bone" 581-588, 2001

      5 "?Multilineage cells from human adipose tissue implications for cell-based therapies" 211-228, 2001

      6 "?Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34 cells in NOD/SCID mice.?Exp. Hematol." 870-878, 2002

      7 "?Isolation of human mesenchymal stem cells" bone marrow versus umbilical cord blood 1099-1100, 2001

      8 "?Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors" 1815-18222001

      9 "?Biology of Hematopoietic Stem Cells Implications for Clinical Application" 759-806, 2003

      10 "P. S. in 't Anker ?Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34 cells in NOD/SCID mice" 881-889, 2003

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-03-28 학회명변경 한글명 : 생체재료학회 -> 한국생체재료학회
      영문명 : 미등록 -> The Korean Society For Biomaterials
      KCI등재후보
      2005-03-28 학술지등록 한글명 : 생체재료학회지
      외국어명 : Biomaterials Research
      KCI등재후보
      2004-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.32 0.32 0.3
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.26 0.23 0.511 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼